Rilutek (Covis Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Rilutek drug offered from Covis Pharmaceuticals, Inc.. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Covis Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: riluzole
SUBSTANCE NAME: RILUZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-07-15
END MARKETING DATE: 0000-00-00


Rilutek HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRilutek from Covis Pharmaceuticals, Inc.
LABELER NAME: Covis Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2013-07-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24987-700_2f204d18-4ce2-43bf-8042-32e6e1ff8712
PRODUCT NDC: 24987-700
APPLICATION NUMBER: NDA020599

Other RILUZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingRILUZOLE
Apotex CorpRILUZOLE
Ascend Laboratories, LLCRiluzole
Covis PharmaRilutek
Covis Pharmaceuticals, Inc.Rilutek
Glenmark Pharmaceuticals Inc., USAriluzole
KAISER FOUNDATION HOSPITALSRilutek
Mylan Pharmaceuticals Inc.Riluzole
Rising Pharmaceuticals, Inc.Riluzole
sanofi-aventis U.S. LLCRilutek
Sun Pharmaceutical Industries LimitedRiluzole